Compound ID | 68
SASPject1.2
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Direct acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Utilises small acid soluble spore proteins which bind to DNA |
| Target Pathogen: | Active against Staphylococcus aureus including methicillin-resistant strains |
| Propensity to select resistant mutants: | Yes |
| Description: | Delivered by bacteriophage |
| Institute where first reported: | Phico Therapeutics Ltd., UK |
| Year first mentioned: | 2014 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://pubmed.ncbi.nlm.nih.gov/34681262/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.